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Background: Catheter-related exit site infection is a major risk factor for the
development of peritonitis and can contribute to failure of treatment maintenance
in peritoneal dialysis (PD) patients. Although povidone-iodine can be used for exit site
care, the irritation induced by the local application of povidone-iodine could lead to
secondary infection. Therefore, we evaluated the clinical effectiveness of normal saline
compared with povidone-iodine as a method of exit site care in chronic PD patients.
Methods: In all, 126 patients undergoing PD treatment for46 months between
January 2006 and December 2009 were enrolled. Data were retrospectively analyzed
for the incidence of exit site infection and peritonitis for 2 years prior to and after
December 2007. In addition, we identiﬁed the incidences of catheter-related infec-
tions during follow-ups from January 2010 to December 2013.
Results: The participants' mean age was 58.8712.9 years. The incidences of exit site
infection and peritonitis were one episode per 64.6 patients–months and
one episode per 40.4 patients–months in the povidone-iodine group, respectively,
whereas these were one episode per 57.5 patients–months and one episode per 45.6
patients–months in the normal saline group, respectively. Whereas Gram-positive
bacteria most frequently caused catheter-related infections in both groups, culture-
negative infections were dominant in the normal saline group.
Conclusion: Exit site care using normal saline did not increase the incidence of
exit site infection and peritonitis. Therefore, normal saline may be an alternative
treatment for exit site care in patients receiving PD.
& 2014. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Chronic kidney disease (CKD) is recognized as a public
health problem, and the number of patients with CKD treated
with renal replacement treatment is increasing. A high rate ofn Society of Nephrology. Publi
c-nd/4.0/).
al Medicine, Dong-A
an 602–715, Korea.
ork.CKD is associated with the elevated prevalence of obesity,
diabetes, hypertension, and increased number of elderly peo-
ple [1–3]. Peritoneal dialysis (PD) is one of the major treat-
ments for patients with end-stage renal disease (ESRD). In
particular, PD is effective in patients affected by severe heart
disease, such as heart failure [4].
Catheter-related infections are considered an important
cause of morbidity in PD patients [5]. In addition, catheter-
related exit site infection is a major risk factor for the develop-
ment of peritonitis and can contribute to treatment failure inshed by Elsevier. This is an open access article under the CC BY-NC-ND
Lee et al / Saline for exit site care 145PD [6]. Prevention of catheter-related infections is a key to
maintaining treatment with PD.
There are several protocols for exit site care. Some authors
have proposed that prophylactic use of antibiotics to the nose
or to the catheter exit site can reduce the incidence of
catheter-related infections [7,8]. Other studies have reported
that the application of topical disinfectants such as povidone-
iodine, water and nondisinfectant soap, or hydrogen peroxide
have beneﬁts in chronic exit site care [9,10]. Povidone-iodine
applied to the catheter exit site reduces the incidence of exit
site-related infections, but the irritation induced by the local
application of povidone-iodine could lead to secondary exit
site infection [11,12]. In addition, a recent report has suggested
that normal saline is more beneﬁcial than povidone-iodine for
preventing exit site infections [4]. However, the question of
whether solutions are more effective for preventing infection
remains unclear.
In this study, we aim to identify differences in the inci-
dences of peritonitis and exit site infection depending on the
exit site care method in patients receiving PD.Methods
Study patients
This study was conducted at Dong-A University Hospital,
Busan, Republic of Korea. In our dialysis center, the exit site
care method changed gradually from povidone-iodine to
normal saline in September 2007, and almost all patients were
treated with saline by December 2007. Therefore, we com-
pared the incidences of exit site infection and peritonitis
between exit site care using povidone-iodine from January
2006 to December 2007 and that using normal saline from
January 2008 to December 2009 (Fig. 1). By December 2009, a
total of 126 patients, including 22 patients using only povi-
done-iodine, 61 patients using only normal saline, and 43
patients who had changed from povidone-iodine to normal
saline for exit site care, were enrolled. Among patients inFigure 1. Flowchartwhom the dressing method was changed, the patients who
received dressings with povidone-iodine were included in the
povidone-iodine group until the dressing method changed
from povidone-iodine to normal saline.
If the dressing method was changed from povidone-iodine
to normal saline, the patients were included in the normal
saline group during dressing with normal saline. In December
2009, 104 patients were enrolled in the normal saline group,
and 65 patients were enrolled in the povidone-iodine group.
Participants were enrolled if they had maintained PD therapy
for46 months between January 1, 2006 and December 31,
2009. The criteria for exclusion included a switch to hemo-
dialysis (HD), kidney transplantation, or death during the
study; patients lost to follow-up because of transfer to another
hospital; patients with suspected technical failure such as
peritonitis or exit site infection within 6 months of starting
PD; patients with repeated peritonitis or exit site infections
within 2 months after previous catheter-related infections; or
disinfectant use ofo6 months.Data collection
Medical records were retrospectively analyzed for the
method of PD, such as continuous ambulatory peritoneal
dialysis (CAPD) or automated peritoneal dialysis, the type of
dialysate, including Physioneal or Dianeal (all from Baxter
Healthcare Corporation, Deerﬁeld, IL, USA), the frequency of
exit site dressing, and the use of tub baths. In addition, we
identiﬁed the incidences of catheter-related infections during
follow-ups from January 2010 to December 2013. During this
interval, if inﬂammation was suspected, the method of dres-
sing was temporarily changed from normal saline to povidone-
iodine.
During the study, side effects of disinfectants including
skin irritation and itching were evaluated. Skin irritation was
deﬁned as erythema, induration, and vesiculation [13]. An
unpleasant sensation that provokes the desire to scratch was
deﬁned as itching [14].of participants.
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Catheter-related infections were deﬁned as exit site infec-
tion and peritonitis. The exit site was assessed at least once a
month by either a nephrologist or dialysis nurse. Exit site swab
cultures from pericatheter skin were taken using sterile
cotton-wool swabs when infection was suspected on the basisTable 1. Clinical characteristics of study participants
Characteristics Values
N 126
Age 58.8712.9
Sex (male) 70 (55.6)
CAPD (vs. APD) 98 (77.8)
Cause of ESRD
Diabetes mellitus 75 (59.5)
Hypertension 32 (25.4)
Glomerulonephritis 9 (7.1)
Other 10 (7.9)
Continuous data are expressed as mean7SD values, and categorical
data are expressed as n (%).
APD, automated peritoneal dialysis; CAPD, continuous ambulatory perito-
neal dialysis; ESRD, end-stage renal disease; PD, peritoneal dialysis; SD,
standard deviation.
Figure 2. Images of the exit site region. Dressed
Table 2. Incidence of catheter-related infections according to the proto
Povidone-iodine (
Cumulative follow-up (patients-months) 1,615
Exit site infection
Number of infections 25
Frequency 1/64.6
(1 episode/patients-months)
Peritonitis
Number of infections 40
Frequency 1/40.4
(1 episode/patients-months)
Side effects
Itching (%) 20 (30.8)
Skin irritation (%) 15 (23.1)of erythema, swelling, induration, soreness, and tenderness at
the exit site [11]. When peritonitis was suspected, peritoneal
efﬂuent cultures were performed. Peritonitis was diagnosed if
the peritoneal ﬂuid was cloudy, the efﬂuent had a white blood
cell count of4100/mm3, and at least 50% of the white blood
cells were polymorphonuclear leukocytes [11].
Statistical analyses
The data are presented as mean7SD (standard deviation) or
frequency (count and percentage). The patients' characteristics
were analyzed using Student t test for continuous variables and
the Chi-square test for categorical variables. The Mann–Whitney
U test analyzed the nonparametric data. All analyses were
conducted using SPSS version 18.0 software (SPSS Inc., Chicago,
IL, USA). A P valueo0.05 was considered statistically signiﬁcant.Results
Baseline characteristics
The clinical characteristics are shown in Table 1. The mean
age of the PD patients was 58.8712.9 years. Seventy (55.6%) ofwith (A) povidone-iodine or (B) normal saline.
col of exit site care
n¼65) Normal saline (n¼104) P
2,645
0.636
46
1/57.5
0.549
58
1/45.6
3 (2.9) o0.001
4 (3.8) o0.001
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were undergoing CAPD. The underlying causes of ESRD
were diabetes mellitus in 75 (59.5%) patients, hypertension in
32 (25.4%) patients, and glomerulonephritis in nine (7.1%) patients.
Incidence of catheter-related infections
Images of exit sites dressed with povidone-iodine (A) or
normal saline (B) are presented in Fig. 2. Sixty-ﬁve patients
treated with povidone-iodine for exit site care were followed
for a total of 1,615 patient-months (Table 2). In patients using
povidone-iodine, the incidences of exit site infections and
peritonitis were 25 (1 episode per 64.6 patients-months) and
40 (1 episode per 40.4 patients-months), respectively. One
hundred and four patients who used normal saline for exit site
care were followed for a total of 2,645 patient-months. Forty-
six patients had exit site infections (1 episode per 57.5
patients-months), and 58 patients had peritonitis (1 episode
per 45.6 patients-months). The differences in the incidences
of exit site infections (P¼0.636) or peritonitis (P¼0.549)
between dressing with povidone-iodine and normal saline
were not statistically signiﬁcant.
Of the participants using povidone-iodine (n¼65), 20
(30.8%) experienced itching and 15 (23.1%) experienced skin
irritation (Table 2). Among them, itching and skin irritation at
the exit site alleviated in 21 (33.9%) patients after the dressing
method was changed from povidone-iodine to normal saline.Table 3. Etiologic organisms of catheter-related infection
Peritonitis
Povidone-iodine Normal saline
Gram stain (þ) 27 35
Staphylococcus 17 20
Streptococcus 5 9
Enterococcus 2 4
Bacillus 1 2
Other 2 0
Gram stain (–) 9 6
Escherichia 3 1
Klebsiella 1 0
Acinetobacter 1 3
Pseudomonas 0 1
Other 4 1
Candida 0 0
Culture-negative 4 17
Total 40 58
Table 4. Incidence of catheter-related infections during the follow-up
Normal saline on
(2,645 patients-mon
Exit site infection
Number of infections 46
Frequency 1/57.5
(1 episode/patients-months)
Peritonitis
Number of infections 58
Frequency 1/45.6
(1 episode/patients-months)
n Normal saline only was deﬁned as the patients using only normal saline f
† Normal saline with povidone-iodine was deﬁned as the patients who were
exit site care, if inﬂammation was suspected.Of the participants using normal saline (n¼104), 7 (6.7%)
experienced side effects such as itching or skin irritation.
There was a signiﬁcant difference in the incidence of side
effects between the povidone-iodine and normal saline groups
(53.8% vs. 7%, Po0.001).
The etiologic organisms of catheter-related infections
are listed in Table 3. Exit site infections and peritonitis were
most often caused by Gram-positive bacteria. Catheter-related
infections caused by Gram-negative bacteria occurred in 11
episodes in the povidone-iodine group and 14 episodes in the
normal saline group. Culture-negative infections were found in
17 (16.3%) cases of peritonitis and nine (8.6%) cases of exit site
infection in the normal saline group and four (6.2%) cases of
peritonitis in the povidone-iodine group; we found no evi-
dence of culture-negative exit site infections in this group.
Culture-negative infections, especially in cases of exit site
infection, were dominant in the normal saline group compared
with the povidone-iodine group (P¼0.019). Chronic exit site
care using normal saline did not increase the incidences of exit
site infection and peritonitis compared with care using povi-
done-iodine; however, the normal saline group had a higher
incidence of culture-negative exit site infections.
A total of 104 patients were followed up from January 2010 to
December 2013 for a total of 3,153 patient-months (Table 4). The
incidences of exit site infection and peritonitis were 53
(1 episode per 59.5 patients-months) and 58 (1 episode per
54.4 patients-months), respectively. Compared with the previousP
Exit site infection
P
Povidone-iodine Normal saline
0.357 22 27 0.311
19 20
2 0
0 1
1 6
0 0
0.077 2 8 0.242
0 0
1 0
0 0
1 6
0 2
1 2 0.870
0.074 0 9 0.019
25 46
ly
ths)n
Normal saline with povidone-iodine
(3,153 patients-months)†
P
0.865
53
1/59.5
0.339
58
1/54.4
or exit site care.
changed the dressing method from normal saline to povidone-iodine for
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similar, but the rate of peritonitis was lower in patients for whom
the mode of dressing was changed than in those for whom
normal saline alone was used. However, there was no signiﬁcant
difference in the incidences of exit site infections (P¼0.865) or
peritonitis (P¼0.339) compared with the previous result. During
the follow-up, 18 (17.3%) patients changed the type of renal
replacement treatment due to recurrent peritonitis (data are not
shown).Discussion
In this study, we found that exit site infection and peritonitis
were not signiﬁcantly associated with the methods of dressing,
but the incidences of side effects such as skin irritation and
itching were signiﬁcantly lower in patients treated with normal
saline than in those treated with povidone-iodine. This result
seems to corroborate that of a recent study completed in Turkey,
in which normal saline use for exit site care was not inferior to
povidone-iodine use with regard to peritonitis and is in fact
superior to povidone-iodine with regard to exit site infection in
children receiving PD [4]. The current study is the ﬁrst study to
evaluate the clinical implications of dressing with normal saline
for exit site care in Korea.
Patients using either normal saline or povidone-iodine had
similar rates of peritonitis and exit site infections in this study.
Regardless of the method of exit site care, Staphylococcuswas the
primary source of both exit site infection and peritonitis. This
result may be explained as the nasal carrier of Staphylococcus is a
high risk of exit site infection compared with no nasal carrier
[15]. The question of how normal saline prevented catheter-
related infections remains unanswered. In this study, the inci-
dence of side effects such as itching and skin irritation increased
when povidone-iodine was applied, but these incidences
decreased after normal saline was used. Based on this result,
one possible explanation is that normal saline may minimize
skin stimulation and thus, decrease skin infections [12,16]. Skin
irritation may represent erythema at the exit site. Previous
studies have reported that erythema alone at the exit site can
be an indicator of exit site infections and peritonitis, subse-
quently requiring catheter removal [17]. In particular, Staphylo-
coccus is the main organism found in erythematous exit site
infections. In our study, dressing with povidone-iodine showed
an elevated risk of skin irritation compared with that of normal
saline. Therefore, dressing with normal saline is effective in
patients with routine exit site care without signs of infection.
Despite many improvements in culture techniques, negative
cultures account for 5–33% of catheter-related infections [18,19].
In this study, the incidence of culture-negative infections was 30
(24%). It is difﬁcult to identify why these infections were culture
negative, but reasons could include a history of recent antibiotic
therapy, invalid sample collection, insufﬁcient bacterial count, and
complex bacterial characteristics. Previous studies have suggested
that negative cultures are largely indicative of infections with
coagulase-negative Staphylococcus. Povidone-iodine can eliminate
viable bacteria from the skin and is likely to contain bactericidal
activity against Staphylococcus [20]. Therefore, povidone-iodine
could be used as an antiseptic for exit site care, although it is
cytotoxic and will delay exit site healing. In the present study,
the frequency of culture-negative catheter-related infections
was higher in the normal saline group than the povidone-
iodine group, but there was no statistically signiﬁcant association.On the basis of these results, we recommended that if an exit site
infection is suspected, the method of dressing should be tem-
porarily changed from normal saline to povidone-iodine until
signs of infection are eliminated. As a result, the incidence of
peritonitis reduced in the povidone-iodine with normal saline
group compared with that in the normal saline alone group,
although the difference in this incidence was not statistically
signiﬁcant. In addition, 18 (17.3%) patients in this study were
transferred to HD due to recurrent peritonitis during the follow-
up. In studies from Scotland, 42.2% patients were transferred to
HD during the 3.5-year follow-up period [21]. In addition,
recurrent peritonitis was associated with a high rate of catheter
removal (37%) in studies from Australia and New Zealand [22].
Compared with previous studies, our study did not show such
a high rate of transfer to HD. Therefore, if inﬂammation is
suspected, povidone-iodine may be recommended.
This study has some limitations. Firstly, as this study was a
retrospective analysis, certain factors such as the method of
catheter insertion and the use of prophylactic antibiotics,
including the topical application of mupirocin or gentamicin,
were not controlled. However, prophylactic antibiotics were
not routinely used for the periods of investigation in our
center. Secondly, because we excluded patients who had
experienced recurrent events within 2 months from previous
catheter-related infections, the incidences of events may have
been underreported. Thirdly, because the number of included
patients was small, the power of the study was limited. Lastly,
from September 2007 to December 2007, the exit site care method
changed from povidone-iodine to normal saline. During this
period, it is ambiguous to reﬂect what kind of disinfectant is
associated with catheter-related infections.
In this study, it was shown that exit site care using normal
saline was not inferior compared with exit site care using
povidone-iodine. Exit site care with normal saline was super-
ior to treatment with povidone-iodine with regard to side
effects. The transient application of povidone-iodine may
provide beneﬁts in patients with signs of inﬂammation. In
conclusion, dressing with normal saline may act as an alter-
native method for the prevention of catheter-related exit site
infections in patients receiving PD. Further comparative stu-
dies are needed to explain the efﬁcacy of normal saline in the
prevention of catheter-related exit site infections in patients
with PD. Studies are also required to reduce the incidence of
Gram-negative infection in this group.Conﬂict of interest
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